drugset / Trial / NCT05745610
Shen Hai Long Capsule for Male Asthenospermia
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of Shen Hai Long Capsule in the treatment of mild to moderate asthenospermia in men.
Timeline
- Start
- 2023-02-15
- Primary completion
- 2024-06-30
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shen Hai Long Capsule | Unknown | — | — |
| Comparator | Sheng Jing Capsule | Unknown | — | — |
Indications
No indication recorded.